Coronavirus Update Debate
Full Debate: Read Full DebateDepartment: Department of Health and Social Care
Mike Wood
Main Page: Mike Wood (Conservative - Dudley South)Department Debates - View all Mike Wood's debates with the Department of Health and Social Care
(3 years, 9 months ago)
Commons ChamberRead Full debate Read Hansard Text Read Debate Ministerial Extracts
Matt Hancock
On the contrary, NHS labs have done an incredibly important job. We have expanded the NHS labs enormously and we have brought in the drive-through centres. This is a massive team effort, and trust among the team is an incredibly important part of getting this right. The hon. Member is absolutely right about concatenating the time taken from the suspicion of someone having covid through not only to getting the test and the result—those times are all coming down—but to the action being taken based on the result, whether that is isolating the contacts of the individual or taking wider action if it is part of a cluster or there are indications that there might have been an outbreak. I entirely agree with the premise of that part of her question. That is a huge and important piece of the work of NHS Test and Trace at the moment. As for the second part of her question, all I would say is that we are doing everything we can to bring the system together, with the support of all those involved.
Mike Wood (Dudley South) (Con)
Most covid deaths in hospitals are now understood to be due to sepsis as a complication. In the light of the former CMO’s concerns about increased antibiotic use during the pandemic, can my right hon. Friend reassure me, first, that the data on covid-90 are granular enough to identify the mode of death of patients in hospitals and, secondly, that the Government will support the NHS if it is challenged when making prescribing decisions in these unimaginably difficult times?
Matt Hancock
My hon. Friend asks an important medical question, and we know that he has a deep personal interest in sepsis. All I can say is that we are constantly learning all the time. I will not try to answer the clinical part of his question—I will leave that to more qualified clinical and medical colleagues—but it is an incredibly important question, and my view is that as much data as possible should be available for research. I have put in place the regulations—and, indeed, a direction —necessary to allow for the research to be done in a much more effective way than was available in the past.